RxDoctor Payments Data

Belinda Wise, NP

Family · Libby, MTNPI 1558735688

Payments from drug & device makers

$376in general payments, 2019–2025

Across 20 payments — averaging $18.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$87
  • Amgen$50
  • CSL Behring$45
  • Boston Scientific$39
  • Ultragenyx Pharmaceutical Inc.$34
  • Pfizer$30
  • plus $92 from 5 others

What the payments were for

  • Food & beverage$376100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$376 in reported general payments places this provider in the 70th percentile of 481 family providers in Montana.

See all family providers in Montana

Medicare billing

Part B allowed, 2024
$1,272
Medicare patients
42
Services billed
84

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban81$62,728
JardianceEmpagliflozin33$29,865
OzempicSemaglutide19$21,172
MounjaroTirzepatide12$14,983
Victoza 3-PakLiraglutide15$12,840
FarxigaDapagliflozin Propanediol19$10,424
Spiriva RespimatTiotropium Bromide11$9,747
Stiolto RespimatTiotropium Br/Olodaterol Hcl12$8,266
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen300$5,804
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen89$2,377
Omeprazole173$2,212
Celecoxib21$2,111
Albuterol Sulfate HfaAlbuterol Sulfate54$2,044
Oxycodone Hcl109$1,790
Levothyroxine Sodium156$1,785

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$30$62,72881 claims
Novo NordiskOzempic$87$21,17219 claims
Lilly USA, LLCMounjaro$17$14,98312 claims
AstraZenecaFarxiga$16$10,42419 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 481 family providers in Montana.

Other family in Libby

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →